ATE231128T1 - Verbindungen mit kondensierten ringen, verfahren zu ihrer herstellung und ihre anwendung - Google Patents

Verbindungen mit kondensierten ringen, verfahren zu ihrer herstellung und ihre anwendung

Info

Publication number
ATE231128T1
ATE231128T1 AT98904386T AT98904386T ATE231128T1 AT E231128 T1 ATE231128 T1 AT E231128T1 AT 98904386 T AT98904386 T AT 98904386T AT 98904386 T AT98904386 T AT 98904386T AT E231128 T1 ATE231128 T1 AT E231128T1
Authority
AT
Austria
Prior art keywords
substituted
group
joints
production
application
Prior art date
Application number
AT98904386T
Other languages
English (en)
Inventor
Tetsuya Aono
Fumio Itoh
Tomohiro Kaku
Masuo Shoyama Villa Yamaoka
Nagata-Ku
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE231128T1 publication Critical patent/ATE231128T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)
AT98904386T 1997-02-21 1998-02-19 Verbindungen mit kondensierten ringen, verfahren zu ihrer herstellung und ihre anwendung ATE231128T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3792797 1997-02-21
PCT/JP1998/000688 WO1998037070A1 (en) 1997-02-21 1998-02-19 Fused ring compounds, process for producing the same and use thereof

Publications (1)

Publication Number Publication Date
ATE231128T1 true ATE231128T1 (de) 2003-02-15

Family

ID=12511197

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98904386T ATE231128T1 (de) 1997-02-21 1998-02-19 Verbindungen mit kondensierten ringen, verfahren zu ihrer herstellung und ihre anwendung

Country Status (8)

Country Link
US (1) US6420375B1 (de)
EP (1) EP0974584B1 (de)
CN (1) CN1251577A (de)
AT (1) ATE231128T1 (de)
AU (1) AU6229698A (de)
CA (1) CA2281598A1 (de)
DE (1) DE69810760T2 (de)
WO (1) WO1998037070A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW407153B (en) * 1997-10-27 2000-10-01 Nippon Kayaku Kk Imidazole compounds and their use
AU1872900A (en) * 1998-12-23 2000-07-31 Astrazeneca Ab Chemical compounds
WO2000042213A1 (en) 1999-01-13 2000-07-20 The Research Foundation Of State University Of New York A novel method for designing protein kinase inhibitors
US6417366B2 (en) * 1999-06-24 2002-07-09 Abbott Laboratories Preparation of quinoline-substituted carbonate and carbamate derivatives
US6552078B2 (en) 1999-10-27 2003-04-22 Nobex Corp 6-methoxy-2-naphthylacetic acid prodrugs
US6436990B1 (en) 1999-10-27 2002-08-20 Nobex Corporation 6-methoxy-2-naphthylacetic acid prodrugs
TWI262791B (en) * 1999-10-27 2006-10-01 Nobex Corp 6-methoxy-2-naphthylacetic acid prodrugs
CA2429133C (en) 2000-11-17 2009-08-18 Takeda Chemical Industries, Ltd. Novel imidazole derivatives, production method thereof and use thereof
DE60144246D1 (de) 2000-11-20 2011-04-28 Takeda Pharmaceutical Imidazolderivate, verfahren zu deren herstellung und deren verwendung
DE60139639D1 (de) 2000-12-08 2009-10-01 Takeda Pharmaceutical Substituierte thiazolderivate mit 3-pyridylgruppen, verfahren zu deren herstellung und deren verwendung
US7005445B2 (en) 2001-10-22 2006-02-28 The Research Foundation Of State University Of New York Protein kinase and phosphatase inhibitors and methods for designing them
MXPA04003758A (es) * 2001-10-22 2005-06-20 Univ New York State Res Found Inhibidores de proteina - cinasas y proteina-fosfatasas, metodos para disenarlos y metodos para usarlos.
WO2003104178A1 (en) * 2002-06-07 2003-12-18 Cortical Pty Ltd Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif)
US7838542B2 (en) 2006-06-29 2010-11-23 Kinex Pharmaceuticals, Llc Bicyclic compositions and methods for modulating a kinase cascade
EP2330909B1 (de) * 2008-08-12 2013-09-18 GlaxoSmithKline LLC Chemische verbindungen
EP2493313B1 (de) 2009-10-29 2017-12-13 Genosco Kinase-inhibitoren
JP6770005B2 (ja) 2016-02-10 2020-10-14 住友化学株式会社 1−メチルピロリジン−3−オールの製造方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3642781A (en) * 1968-10-15 1972-02-15 Warner Lambert Co Substituted acrylic acids and process for their production
US4237133A (en) * 1977-11-14 1980-12-02 Pfizer Inc. 1,9-Dihydroxyoctahydrophenanthrenes
GB8417559D0 (en) * 1984-07-10 1984-08-15 Pfizer Ltd Anti-diarrhoeal agents
LU86022A1 (fr) * 1985-07-25 1987-02-04 Cird Derives aromatiques polycyliques,leur procede de preparation et leur application dans les domaines pharmaceutique et cosmetique
NZ221729A (en) * 1986-09-15 1989-07-27 Janssen Pharmaceutica Nv Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions
JP2852659B2 (ja) * 1988-03-03 1999-02-03 富山化学工業株式会社 ピペラジン誘導体およびその塩
JPH07121933B2 (ja) 1988-03-28 1995-12-25 キッセイ薬品工業株式会社 ジヒドロベンゾフラノン誘導体
US5273977A (en) * 1990-11-05 1993-12-28 Warner-Lambert Company Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents
JP3157882B2 (ja) 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
GB9220735D0 (en) * 1992-10-02 1992-11-18 British Tech Group Heterocyclic amines
JPH06293640A (ja) 1993-02-15 1994-10-21 Shin Nippon Yakuhin Kk 肝疾患治療剤および1,3−ベンゾキサチオール誘導体
JPH06239856A (ja) 1993-02-15 1994-08-30 Shin Nippon Yakuhin Kk 1,3−ベンゾオキサチオール−2−チオン誘導体
GB9310635D0 (en) * 1993-05-21 1993-07-07 Glaxo Group Ltd Chemical compounds
PL313769A1 (en) 1993-09-30 1996-07-22 Yamanouchi Pharma Co Ltd Azole derivative and pharmaceutical composition thereof
JPH07173120A (ja) 1993-10-08 1995-07-11 Banyu Pharmaceut Co Ltd 置換芳香族カルボン酸誘導体
AU4536096A (en) * 1995-01-10 1996-07-31 Smithkline Beecham Spa Indole derivatives useful in the treatment of osteoporosis
AU4547896A (en) 1995-02-03 1996-08-21 Banyu Pharmaceutical Co., Ltd. 4-oxo-2-butenoic acid derivatives
WO1997017321A1 (fr) 1995-11-07 1997-05-15 Banyu Pharmaceuticals Co., Ltd. Derives cycliques d'acide amique
NZ323521A (en) 1995-12-06 1999-10-28 Astra Pharma Prod Compounds for treating reversible obstructive airway disease or allergic conditions
EP0887340A4 (de) * 1996-02-06 2000-03-29 Japan Tobacco Inc Chemische verbindungen und deren pharmazeutische verwendungen
FR2746098B1 (fr) 1996-03-14 1998-04-30 Composes propynyl biaromatiques
MY118876A (en) 1996-03-29 2005-02-28 Tanabe Seiyaku Co Butadiene derivatives and process for preparing thereof
BR9710230A (pt) * 1996-07-09 1999-08-10 Smithkline Beecham Spa Derivados de indol para o tratamento de osteoporose
US6005000A (en) * 1996-08-22 1999-12-21 Oxis International, Inc. 5,5-Disubstituted-3, 4-dihydroxy-2(5H)-furanones and methods of use therefor

Also Published As

Publication number Publication date
EP0974584A1 (de) 2000-01-26
DE69810760D1 (de) 2003-02-20
EP0974584A4 (de) 2000-05-17
EP0974584B1 (de) 2003-01-15
CA2281598A1 (en) 1998-08-27
DE69810760T2 (de) 2003-11-20
AU6229698A (en) 1998-09-09
CN1251577A (zh) 2000-04-26
US6420375B1 (en) 2002-07-16
WO1998037070A1 (en) 1998-08-27

Similar Documents

Publication Publication Date Title
ATE231128T1 (de) Verbindungen mit kondensierten ringen, verfahren zu ihrer herstellung und ihre anwendung
ATE131470T1 (de) Neue arylethenylenderivate und verfahren zu ihrer herstellung
DE69532817D1 (de) Verwendung von pyrazole verbindungen zur behandlung von glomerulonephritis, krebs, atherosklerose oder restenose
ATE37375T1 (de) Phosphonyl-hydroxyacyl-aminosaeure-derivate und ihre verwendung als antihypertensiva.
DE69835877D1 (de) Trizyklische verbindungen
DE69823344D1 (de) Substituierte benzimidazol-derivaten und ihre verwendung zur behandlung retroviraler infektionen
ATE241625T1 (de) Heterocyclische verbindungen, ihre herstellung und verwendung
CA2236814A1 (en) Quinoline and quinazoline compounds useful in therapy
ATE173165T1 (de) Zusammensetzung, verfahren und instrument zur potenzierung der antitumoraktivität und zur behandlung von tumoren
ATE361748T1 (de) 1-(4-sulfamylphenyl)-3-trifluormethyl-5-aryl-2- pyrazoline als cyclooxygenase-2 inhibitoren
DE69331171D1 (de) Chinolin und Chinazolin Derivate zur Behandlung von Arthritis
ATE159514T1 (de) Substituierte aminsäure derivate verwendbar für die behandlung von arteriosclerosis
MY128323A (en) Thiazole derivatives for inhibition of cytokine production and of cell adhesion
NO913566L (no) Aryl-kondenserte- og hetaryl-kondenserte-2,4-diazepin-og-2,4-diazocinforbindelser og fremgangsmaate for deres fremstilling.
DE69636048D1 (de) Piperazin- und Homopiperazinderivate zur Hemmung der Zellenadhäsion und Zelleninfiltration
ATE46159T1 (de) Pyridazinone, inotrope mittel.
ES8801545A1 (es) Un procedimiento para la preparacion de compuestos aminoheterociclicos
DE69629133D1 (de) Substituierte Aminochinazolinon (thion) Derivate
ATE502030T1 (de) Imidazolderivate, verfahren zu deren herstellung und deren verwendung
AU539177B2 (en) Amino alkoxy pyrazoles
ATE241976T1 (de) N,n'-bis (sulfonyl) hydrazine die als antineoplastische mittel nützlich sind
EA200100155A2 (ru) Новые производные 6-амино или 6-гидразиносульфонил-3-хинолинилфосфоновой кислоты, способ их получения и содержащие их фармацевтические композиции
DE69626846D1 (de) Phosphonsäurederivate mit metallopeptidase inhibierender aktivität
DE60000405D1 (de) 1,4-disubstitutierte cyclohexanderivate zur behandlung von depression
ATE227718T1 (de) N-aryloxyethyl-indolyl-alkylamine zur behandlung von depressionen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties